BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Job Trends

  Bristol Myers Squibb to Participate in Bank of America Securities 2022 Healthcare Conference

  Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Bank of America Securities 2022 Healthcare Conference in Las Vegas, Nevada on Wednesday, May 11, 2022.

  May 4, 2022

   · 

  1 min read
• Business

  Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results

  Cardiovascular Systems, Inc. today reported financial results for its third quarter, ended March 31, 2022.

  May 4, 2022

   · 

  21 min read
• Genetown

  Apertura Announces Fit4Function AAV Capsid Engineering Platform and In Vivo Proof-of-Concept Data to Be Presented at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

  Apertura Announces Fit4Function AAV Capsid Engineering Platform and In Vivo Proof-of-Concept Data to Be Presented at the 25th Annual Meeting of the American Society of Gene and Cell Therapy.

  May 4, 2022

   · 

  3 min read
• Business

  Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results

  Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced financial results for the first quarter ended March 31, 2022, and provided a corporate update.

  May 4, 2022

   · 

  13 min read
• Business

  Bruker Reports First Quarter Financial Results

  Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2022.

  May 4, 2022

   · 

  19 min read
• Pharm Country

  Humanigen Announces Participation and Presentation at Multiple Conferences in May

  Humanigen, Inc. announced today that management will present and participate at multiple investors conferences in May 2022.

  May 4, 2022

   · 

  4 min read
• FDA

  FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions

  Orthofix Medical Inc today announced the U.S. Food and Drug Administration (FDA) pre-market approval for the AccelStim ™ bone healing therapy Class III device.

  May 4, 2022

   · 

  5 min read
• ADC Therapeutics to Present at the BofA Securities 2022 Healthcare Conference

  ADC Therapeutics SA announced today that its executives will be participating in a fireside chat at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10, 2022, at 1:40 pm ET.

  May 4, 2022

   · 

  2 min read
• Deals

  Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements

  Diffusion Pharmaceuticals Inc. today announced that it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the Nasdaq minimum bid price.

  May 4, 2022

   · 

  2 min read
• Drug Development

  Genenta Progresses to Higher Dosing Cohort in Temferon™ Phase 1/2a Clinical Trial in Glioblastoma Multiforme

  Genenta Science announces that its ongoing trial of Temferon™ in glioblastoma multiforme patients who have an unmethylated MGMT gene promoter (uMGMT-GBM) has escalated to the next planned dose.

  May 4, 2022

   · 

  4 min read